Vivamed Pharmaceuticals Private Limited

Vivamed Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24304TG2019PTC133993 Incorporated 10 July 2019 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹20.74 Lakh
▲ 36% YoY
Net profit · FY 2025
₹73,220
Net margin 3.5%
EBITDA · FY 2025
₹1.61 Lakh
EBITDA margin 7.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Vivamed Pharmaceuticals Private Limited

Data last updated:

Vivamed Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 July 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2019PTC133993. Its GSTIN is 36AAHCV0123B1ZX (Telangana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinaya Shankar Yerrolla and Raghuvamshi Swapna.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 8 – 30/4/4/44 Flat No 201 Dhana Laxmi Apartments Block B Edhaiah Nagar, Hyderabad, Telangana, India – 500036.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.74 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹73,220 (net margin 3.5%) and EBITDA of ₹1.61 Lakh (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 24% over five years.

Vivamed Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0058325).

Company details

CIN U24304TG2019PTC133993
Registration Number 133993
Incorporation Date 10 July 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0058325

Recognitions & Rankings of Vivamed Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0058325

Contact details

Vivamed Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    H No 8 – 30/4/4/44 Flat No 201 Dhana Laxmi Apartments Block B Edhaiah Nagar, Hyderabad, Telangana, India – 500036
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Vivamed Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Vivamed Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Vivamed Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Vivamed Pharmaceuticals Private Limited, buy the company report.

Financials of Vivamed Pharmaceuticals Private Limited

FY 2025 filings available

Vivamed Pharmaceuticals Private Limited reported revenue of ₹20.74 Lakh (up 36% YoY) for FY 2025.

Revenue · FY 2025
₹20.74 Lakh ▲ 36%
Net profit · FY 2025
₹73,220 margin 3.5%
EBITDA · FY 2025
₹1.61 Lakh margin 7.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 2%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 32%
5 years · compounded
▲ 37%

Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 36% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.61 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹73,220
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.8%
Net Profit Margin3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vivamed Pharmaceuticals Private Limited, buy the company report.

Board of directors of Vivamed Pharmaceuticals Private Limited

Vivamed Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinaya Shankar YerrollaDirector10 Jul 20197 Years 4 MonthsCurrent
Raghuvamshi SwapnaDirector23 Mar 20224 Years 7 MonthsCurrent

Peer comparison

Vivamed Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sentire Pharmaceuticals India Private Limited₹20.76 Lakh (FY 2019)-50.0%Chandigarh, India
Kishri Pharma Private Limited₹20.75 Lakh (FY 2024)-37.0%Deoghar, Jharkhand, India
Krishabh Pharmaceuticals Private Limited₹20.75 Lakh (FY 2025)1191.0%Bettiah, Bihar, India
Vivamed Pharmaceuticals Private Limitedthis company₹20.74 Lakh (FY 2025)₹73,2203.5%36.0%Hyderabad, Telangana, India
Alvitas Pharmaceuticals Private Limited₹20.7 Lakh (FY 2021)Upper Bazar, Ranchi, Jharkhand, India

To see the full peer comparison of Vivamed Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vivamed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Vivamed Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAHCV0123B1ZXTelanganaActive24 Jul 2019

To see the full GST registrations and return filing status of Vivamed Pharmaceuticals Private Limited, buy the company report.

Recent activity

Vivamed Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Pavan Kumar Janagama ceased to be Director on 24 Mar 2022.

AGM
Vivamed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vivamed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Pavan Kumar Janagama ceased to be Director.
Appointed
Raghuvamshi Swapna was appointed as Director.
Appointed
Vinaya Shankar Yerrolla was appointed as Director.
Incorporation
10 Jul 2019
Vivamed Pharmaceuticals Private Limited was registered on 10 Jul 2019 with Roc Hyderabad & aged 7 years 4 months as per MCA records.

Frequently asked questions

Vivamed Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 July 2019 (7+ years old) and is registered under CIN U24304TG2019PTC133993.

Vivamed Pharmaceuticals has 2 current directors:

The latest financial statements of Vivamed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Vivamed Pharmaceuticals is 36AAHCV0123B1ZX, registered in Telangana.

The CIN (Corporate Identification Number) of Vivamed Pharmaceuticals is U24304TG2019PTC133993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vivamed Pharmaceuticals was incorporated on 10 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Vivamed Pharmaceuticals by revenue are Sentire Pharmaceuticals India Private Limited, Kishri Pharma Private Limited, Krishabh Pharmaceuticals Private Limited, Alvitas Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Pavan Kumar Janagama ceased to be Director on 24 Mar 2022. Raghuvamshi Swapna was appointed as Director on 23 Mar 2022. Vinaya Shankar Yerrolla was appointed as Director on 10 Jul 2019.

Yes, Vivamed Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0058325).

The registered office of Vivamed Pharmaceuticals is at H No 8 – 304444 Flat No 201 Dhana Laxmi Apartments Block B Edhaiah Nagar, Hyderabad, Telangana, India – 500036.

Vivamed Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.